logo-loader

Canntab Therapeutics wins Health Canada hemp cultivation license

Published: 16:41 22 May 2019 EDT

Canntab Therapeutics Limited (CSE:PILL.CN) (OTCMKTS:CTABF) CFO Richard Goldstein tells Proactive Investors the Canadian company has achieved a major milestone by receiving a cultivation license from Health Canada.

The license allows Canntab to cultivate industrial hemp, said Goldstein adding it intends to use the license to secure hemp biomass that it will use to extract CBD to manufacture cannabis hard pills.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

2 hours, 52 minutes ago